Carbamazepine Tablet, Chewable
NDC Package 13668-271-49
Package Information
Carbamazepine tablets is carbamazepine is used to prevent and control seizures. This formulation utilizes a tablet, chewable delivery system. Marketed by Torrent Pharmaceuticals Limited, this product is identified by NDC 13668-271 and is authorized under FDA application ANDA075712.
Identification & Billing
- RxCUI: 308973 - carBAMazepine 100 MG Chewable Tablet
- RxCUI: 308973 - carbamazepine 100 MG Chewable Tablet
- RxCUI: 308979 - carBAMazepine 200 MG Oral Tablet
- RxCUI: 308979 - carbamazepine 200 MG Oral Tablet
Clinical Specifications
- Cytochrome P450 1A2 Inducers - [MoA] (Mechanism of Action)
- Cytochrome P450 2B6 Inducers - [MoA] (Mechanism of Action)
- Cytochrome P450 2C19 Inducers - [MoA] (Mechanism of Action)
- Cytochrome P450 2C9 Inducers - [MoA] (Mechanism of Action)
- Cytochrome P450 3A4 Inducers - [MoA] (Mechanism of Action)
- Decreased Central Nervous System Disorganized Electrical Activity - [PE] (Physiologic Effect)
- Mood Stabilizer - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 13668 - Torrent Pharmaceuticals Limited
- 13668-271 - Carbamazepine
- 13668-271-49 - 750 TABLET, CHEWABLE in 1 BOTTLE
- 13668-271 - Carbamazepine
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (13668-271). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 13668-271-49 identifies a specific commercial package of 750 tablet, chewable in 1 bottle of Carbamazepine, a human prescription drug labeled by Torrent Pharmaceuticals Limited. This tablet, chewable is formulated for oral use and contains carbamazepine as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Torrent Pharmaceuticals Limited on August 26, 2009. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
Carbamazepine is used to prevent and control seizures. This medication is known as an anticonvulsant or anti-epileptic drug. It is also used to relieve certain types of nerve pain (such as trigeminal neuralgia). This medication works by reducing the spread of seizure activity in the brain and restoring the normal balance of nerve activity.
How is this Torrent Pharmaceuticals Limited product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 13668027149. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.